Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.458 USD | +1.28% | +1.42% | -68.71% |
05-06 | Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib | MT |
05-06 | RedHill Biopharma Ltd. Announces New Opaganib Chinese Patent against Ebola Virus Valid Through 2035 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-68.71% | 14.41M | |
-3.35% | 88.91B | |
+2.76% | 41.25B | |
-14.35% | 31.99B | |
+50.51% | 24.73B | |
-15.00% | 15.54B | |
-39.93% | 12.07B | |
-9.08% | 12.05B | |
-15.21% | 12.02B | |
+6.22% | 8.84B |
- Stock Market
- Equities
- RDHL Stock
- News RedHill Biopharma Ltd.
- Redhill Biopharma : Shares Climb after Cantor Fitzgerald Initiates Coverage With Overweight Rating